These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7045328)

  • 21. [Anti-platelet aggregation effect of PGI2 potentiated by EG-626].
    Tanaka K; Harada Y; Katori M
    Rinsho Byori; 1979; Suppl 40():188-91. PubMed ID: 399308
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of acetylsalicyclic and nicotinic acids and complamin on the formation of a prostacyclin-like substance by the aortic wall].
    Lakin KM; Baluda VP; Lukoianova TI; Romanovskaia VN; Baluda MV
    Farmakol Toksikol; 1980; 43(5):581-5. PubMed ID: 7004908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of ibuprofen dose on rabbit platelet aggregation and aortic pgi2 synthesis.
    Adesuyi SA; Ellis EF
    Thromb Res; 1982 Nov; 28(4):581-5. PubMed ID: 6761894
    [No Abstract]   [Full Text] [Related]  

  • 24. [Molecular action of drugs affecting platelet functions (author's transl)].
    Verstraete M
    Rev Med Brux; 1981 Mar; 2(3):301-8. PubMed ID: 6262895
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of heparin on prostacyclin activity of the aorta wall].
    Baluda VP; Sushkevich GN; Liasko LI
    Biull Eksp Biol Med; 1982 Sep; 94(9):79-80. PubMed ID: 6756506
    [No Abstract]   [Full Text] [Related]  

  • 26. [Prostaglandins: physiological or "foreign" molecules? Some ticklish questions. Biosynthesis. Nutrition. Pathology (author's transl)].
    Devis R
    J Pharm Belg; 1981; 36(1):43-72. PubMed ID: 7014826
    [No Abstract]   [Full Text] [Related]  

  • 27. Inhibitory effects of copper-aspirin complex on platelet aggregation.
    Shen ZQ; Chen ZH; Ma GY; Wang DC; Wu WL; Liu WP; Yang YK; Xiong HZ
    Zhongguo Yao Li Xue Bao; 1997 Jul; 18(4):358-62. PubMed ID: 10072923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The role of prostacycline, thromboxane A2 and prostaglandins in platelet aggregation (author's transl)].
    Herman AG
    Rev Med Brux; 1981 Mar; 2(3):251-7. PubMed ID: 7015444
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhibition of vascular and platelet prostaglandin synthesis by aspirin.
    N Engl J Med; 1983 Sep; 309(11):670-2. PubMed ID: 6350874
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of choline magnesium trisalicylate on prostacyclin production by isolated vascular tissue of the rat.
    Levy JV
    Thromb Res; 1983 Jan; 29(2):149-54. PubMed ID: 6342204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Function of prostaglandins in platelet aggregation].
    Sun QW
    Sheng Li Ke Xue Jin Zhan; 1980 Feb; 11(2):137-42. PubMed ID: 7001620
    [No Abstract]   [Full Text] [Related]  

  • 32. The evaluation and structure-activity relationships of 2-benzoylaminobenzoic esters and their analogues as anti-inflammatory and anti-platelet aggregation agents.
    Hsieh PW; Hwang TL; Wu CC; Chiang SZ; Wu CI; Wu YC
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1812-7. PubMed ID: 17197180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile.
    Argentieri DC; Ritchie DM; Ferro MP; Kirchner T; Wachter MP; Anderson DW; Rosenthale ME; Capetola RJ
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1399-408. PubMed ID: 7996452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of prostaglandin E1 on in vitro and in vivo platelet aggregation with special reference to thrombus formation (author's transl)].
    Kobayashi N; Araki H
    Nihon Ketsueki Gakkai Zasshi; 1974 Apr; 37(2):166-73. PubMed ID: 4471800
    [No Abstract]   [Full Text] [Related]  

  • 35. Anti-inflammatory and anti-platelet aggregation activity of human placental extract.
    Sur TK; Biswas TK; Ali L; Mukherjee B
    Acta Pharmacol Sin; 2003 Feb; 24(2):187-92. PubMed ID: 12546729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostacyclin in blood vessel-platelet interactions: perspectives and questions.
    Needleman P
    Nature; 1979 May; 279(5708):14-5. PubMed ID: 377090
    [No Abstract]   [Full Text] [Related]  

  • 37. [Inhibitory effect of EB-382, a non-steroidal antiinflammatory agent, on platelet aggregation].
    Fujiyoshi T; Iida H; Murakami M; Uematsu T
    Yakugaku Zasshi; 1987 Jan; 107(1):76-81. PubMed ID: 3585712
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of ticlopidine and acetylsalicylic acid on generation of prostaglandin I2-like substance in rat arterial tissue.
    Ashida S; Abiko Y
    Thromb Res; 1978 Nov; 13(5):901-8. PubMed ID: 369031
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacological effects of three phenylpropanoid glycosides from Mussatia.
    Cano E; Veiga M; Jiménez C; Riguera R
    Planta Med; 1990 Feb; 56(1):24-6. PubMed ID: 2356239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of 3,4-dihydroxyacetophenone on the generation of PGI2-like substances in the rat aorta].
    Wang Z; Gao HG; Zhu GQ; An Y; Huang RS
    Zhongguo Yao Li Xue Bao; 1986 Jan; 7(1):37-40. PubMed ID: 2945382
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.